Predictive prognostic value of glomerular C3 deposition in IgA nephropathy

被引:15
|
作者
Xie, Minhua [1 ,2 ]
Zhu, Yuze [1 ,2 ]
Wang, Xutong [1 ,2 ]
Ren, Jingjing [1 ,2 ]
Guo, Haonan [1 ,2 ]
Huang, Bo [1 ,2 ]
Wang, Shulei [1 ,2 ]
Wang, Peiheng [1 ,2 ]
Liu, Yiming [1 ,2 ]
Liu, Yingchun [1 ,2 ]
Zhang, Junjun [1 ,2 ]
机构
[1] Zhengzhou Univ, Dept Nephrol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Res Inst Nephrol, Zhengzhou, Henan, Peoples R China
关键词
IgA nephropathy; C3; deposition; The Oxford classification; Prognosis; OXFORD CLASSIFICATION; COMPLEMENT ACTIVATION; ALTERNATIVE PATHWAY; OUTCOMES; INJURY;
D O I
10.1007/s40620-022-01363-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background IgAN is the most common primary glomerulonephritis worldwide. However, the pathogenesis of IgAN remains unknown. Currently, there is evidence that C3 deposition plays a role in disease development. This study aimed to investigate clinical, pathological features, and prognosis of adult IgAN patients with C3 deposition, as well as explore the role of complement activation in disease progression. Methods A total of 821 patients with biopsy-proven IgAN were included in this study. Patients were divided into three different groups according to their C3 deposition intensity. Clinical and pathological characteristics were compared between groups. Logistic analysis was used to estimate the relationship between C3 deposition and the Oxford scoring system. Univariate and multivariate Cox proportional hazard regression models were used to analyze the effect of the presence of C3 deposits on the prognosis of patients with IgA nephropathy. Kaplan-Meier survival analysis was used to evaluate the cumulative incidence of renal progression between groups. Results Patients with C3 deposition exhibited more severe clinical and pathological features and had a higher score according to the Oxford scoring system. With the increasing intensity of C3 deposition, patients present more hematuria, crescents, heavier interstitial inflammatory cell infiltration and a higher score on segmental sclerosis lesions. Logistic regression identified a positive relationship between C3 deposition and histopathology. Univariate and multivariate Cox regression indicated that C3 deposition was an independent risk factor for IgAN severity. The Kaplan-Meier survival curves indicated that patients with positive C3 deposition had a worse prognosis compared to those without C3 deposition. Conclusions Patients with positive glomerular C3 deposition presented with more severe clinical and histopathological characteristics and a higher score on the Oxford scoring system. With the increasing intensity of C3 deposition, IgAN patients were more likely to present with high level of microscopic hematuria, fibrous crescents, interstitial inflammatory cell infiltration, and a higher score on segmental sclerosis lesions. C3 deposition at the time of renal biopsy is likely an independent risk factor for IgA nephropathy severity and progression. [GRAPHICS] .
引用
收藏
页码:495 / 505
页数:11
相关论文
共 50 条
  • [41] Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
    Aizawa, Masashi
    Suzuki, Yusuke
    Suzuki, Hitoshi
    Pang, Huihua
    Kihara, Masao
    Nakata, Junichiro
    Yamaji, Kenji
    Horikoshi, Satoshi
    Tomino, Yasuhiko
    PLOS ONE, 2014, 9 (04):
  • [42] Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy
    Wu, Jianliang
    Hu, Zhizhi
    Wang, Yuxi
    Hu, Danni
    Yang, Qian
    Li, Yueqiang
    Dai, Wei
    Zhu, Fengming
    Yang, Juan
    Wang, Meng
    Zhu, Han
    Liu, Liu
    He, Xiaofeng
    Han, Min
    Yao, Ying
    Pei, Guangchang
    Zeng, Rui
    Xu, Gang
    HISTOPATHOLOGY, 2021, 78 (06) : 882 - 895
  • [43] The Clinical and Pathological Effects of Serum C3 Level and Mesangial C3 Intensity in Patients with IgA Nephropathy
    Hou, Xiaoyue
    Liang, Yanan
    Zhang, Weiwei
    Li, Rong
    ANALYTICAL CELLULAR PATHOLOGY, 2024, 2024
  • [44] Renal cortical complement C3 gene expression in IgA nephropathy
    Montinaro, V
    Gesualdo, L
    Ranieri, E
    Monno, R
    Grandaliano, G
    Schena, FP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 (03): : 415 - 425
  • [45] Analysis of glomerular deposition of IgM and C3 in patients with podocytopathies
    Ferreira, Veronica Aparecida
    da Silva, Crislaine Aparecida
    Neto, Jose Rodrigues do Carmo
    Rocha, Laura Penna
    Martins, Ana Luisa Monteiro dos Santos
    dos Reis, Marlene Antonia
    Machado, Juliana Reis
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 70
  • [46] GLOMERULAR DEPOSITION OF IMMUNE-COMPLEXES IN EXPERIMENTAL IGA NEPHROPATHY
    RIFAI, A
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 530 - 530
  • [47] AIM(CD5L) REGULATES GLOMERULAR IGA DEPOSITION AND ITS PHLOGOGENISITY IN IGA NEPHROPATHYREGULATES THE GLOMERULAR IGA DEPOSITION AND ITS PHLOGOGENISITY IN IGA NEPHROPATHY
    Takahata, Akiko
    Kitada, Kento
    Nogi, Chieko
    Arai, Satoko
    Makita, Yuko
    Suzuki, Hitoshi
    Nakata, Junichiro
    Horikoshi, Satoshi
    Miyazaki, Toru
    Suzuki, Yusuke
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 101 - 102
  • [48] UTILITY OF SERUM IGA/C3 RATIO IN PREDICTING RENAL DISEASE PROGRESSION IN IGA NEPHROPATHY
    Mohammed, Sophia
    Chinnadurai, Rajkumar
    Ponnusamy, Arvind
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [49] Serum IgA/C3 ratio: a useful marker of disease activity in patients with IgA nephropathy
    Torikoshi, Kazuo
    Endo, Tomomi
    Tsukamoto, Tatsuo
    Yasuda, Takashi
    Yasuda, Yoshinari
    Kawamura, Tetsuya
    Matsuo, Seiichi
    Suzuki, Yusuke
    Muso, Eri
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (10) : 3389 - 3396
  • [50] Is There a Role for IgA/C3 Ratio in IgA Nephropathy Prognosis? An Outcome Analysis on An European Population
    Stefan, Gabriel
    Stancu, Simona
    Boitan, Bianca
    Zugravu, Adrian
    Petre, Nicoleta
    Mircescu, Gabriel
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2020, 14 (06) : 470 - 477